Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD


Budesonide (BUD) is a steroid with a low bioavailability, which has been used for the treatment of oral manifestations of chronic GVHD (cGVHD). We retrospectively evaluated the efficacy of BUD in the treatment of gastrointestinal cGVHD. Thirteen patients (median age 47 years) receiving BUD for the treatment of cGVHD after allogeneic hematopoietic SCT for… (More)
DOI: 10.1038/bmt.2008.209


2 Figures and Tables